Development
AbCellera Biologics Inc.
ABCL
$4.59
$0.092.00%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.21% | -1.24% | -0.10% | -10.15% | 2.11% |
| Total Receivables | 71.93% | -18.02% | -54.12% | -3.71% | -2.41% |
| Inventory | -7.29% | -17.48% | 0.00% | -5.55% | -- |
| Prepaid Expenses | -34.66% | 43.11% | 23.26% | 100.15% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -60.34% | -3.84% | 162.22% | 0.00% | -65.03% |
| Total Current Assets | -5.17% | -1.21% | -1.05% | -8.27% | -1.93% |
|
|
|||||
| Total Current Assets | -5.17% | -1.21% | -1.05% | -8.27% | -1.93% |
| Net Property, Plant & Equipment | 3.78% | 6.77% | 11.34% | 7.33% | 8.30% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -2.94% | -2.11% | -1.63% | -2.02% | -7.75% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 94.74% | -40.36% | 34.92% | -28.76% | 2.63% |
| Total Assets | -1.59% | -1.62% | 2.62% | -2.79% | -0.74% |
|
|
|||||
| Total Accounts Payable | 46.33% | -17.09% | 19.67% | 18.49% | 59.12% |
| Total Accrued Expenses | 14.36% | 35.84% | 42.30% | -81.06% | 9.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.52% | -6.40% | 1.45% | 5.10% | 23.60% |
| Total Finance Division Other Current Liabilities | -1.60% | -8.45% | 38.69% | -15.03% | 5.04% |
| Total Other Current Liabilities | -1.60% | -8.45% | 38.69% | -15.03% | 5.04% |
| Total Current Liabilities | 7.96% | -7.29% | 32.72% | -24.28% | 11.57% |
|
|
|||||
| Total Current Liabilities | 7.96% | -7.29% | 32.72% | -24.28% | 11.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.27% | -3.71% | 1.05% | 0.77% | 7.10% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.08% | -0.94% | 18.60% | 8.81% | -9.60% |
| Total Liabilities | 1.93% | -3.78% | 18.28% | -5.92% | 1.78% |
|
|
|||||
| Common Stock & APIC | 1.98% | 1.92% | 2.03% | 1.97% | 1.72% |
| Retained Earnings | -14.42% | -8.05% | -7.91% | -9.41% | -6.55% |
| Treasury Stock & Other | -17.81% | 23.12% | 6.04% | -45.29% | -94.00% |
| Total Common Equity | -2.58% | -1.01% | -1.13% | -2.01% | -1.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.58% | -1.01% | -1.13% | -2.01% | -1.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.58% | -1.01% | -1.13% | -2.01% | -1.35% |
|
|
|||||